S2049Introduced in the Senate
Establishes a program within the adult correctional institution to permit medication assisted treatment approved by the FDA to be provided for the treatment of opioid use disorder to any incarcerated individual.
Introduced by Meghan Kallman, District 15
What does this bill do?
Plain-English breakdown
Writing a plain-English summary of this bill… this can take a few seconds the first time.
Official description
STATE AFFAIRS AND GOVERNMENT -- CORRECTIONS DEPARTMENT - Establishes a program within the adult correctional institution to permit medication assisted treatment approved by the FDA to be provided for the treatment of opioid use disorder to any incarcerated individual.
Where it stands
Committee recommended measure be held for further study
May 7, 2026
How did lawmakers vote?
SenateStage: Senate Committee on Judiciary: Be held for further study · May 7, 2026
9
Yes
0
No
2
Absent or Not Voting
11 senators recorded in this Senate vote. Colors show vote categories only, not whether a vote was good or bad.
What do people think?
Citizen Voice
How would you vote on this bill?
An unofficial public opinion poll. It does not affect the bill or the official vote.
One response per device. Location is self-reported and not verified. Results are informal and not a scientific survey.
See how each senator voted
| Senator | District | Vote |
|---|---|---|
| Jacob Bissaillon | 1 | Absent |
| Ana Quezada | 2 | Yes |
| John Burke | 9 | Yes |
| Dawn Euer | 13 | Yes |
| Thomas Paolino | 17 | Yes |
| Jessica de la Cruz | 23 | Yes |
| Andrew Dimitri | 25 | Absent |
| Todd Patalano | 26 | Yes |
| Mark McKenney | 30 | Yes |
| Matthew LaMountain | 31 | Yes |
Bill history
Introduced, referred to Senate Judiciary
Scheduled for hearing and/or consideration (05/07/2026)
Committee recommended measure be held for further study
Verify the information
Our commitment to neutrality
We provide factual information only. We never tell you which politicians or bills to support, and we do not rank, score, or endorse anyone.